EUVIMEDEUVIMED entdecken
Crossref

Membrane‐Fusion‐Mediated Multiplex Engineering of Tumor Cell Surface Glycans for Enhanced NK Cell Therapy

Chunxiong Zheng, Qingguo Zhong, Wantong Song, Ke Yi, Huimin Kong, Haixia Wang, Yu Tao, Mingqiang Li, Xuesi Chen iD

Advanced Materials · 2023

DOI: 10.1002/adma.202206989 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2023. Verfasst von Chunxiong Zheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biomaterials and Translational Medicine, Center for Nanomedicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510…. Hauptthemen laut MEDLINE: N-Acetylneuraminic Acid, Neoplasms. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Science and Technology Program of Guangzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural killer (NK) cell therapies show potential for tumor treatment but are immunologically resisted by the overexpressed immunosuppressing tumor cell surface glycans. To reverse this glycan‐mediated immunosuppression, the surface NK‐inhibitory glycan expressions need to be downregulated and NK‐activating glycan levels should be elevated synchronously with optimal efficiency. Here, a core–shell membrane‐fusogenic liposome (MFL) is designed to simultaneously achieve the physical modification of NK‐activating glycans and biological inhibition of immunosuppressing glycans on the tumor cell surface via a membrane‐fusion manner. Loaded into a tumor‐microenvironment‐triggered‐degradable thermosensitive hydrogel, MFLs could be conveniently injected and controllably released into local tumor. Through fusion with tumor cell membrane, the released MFLs could simultaneously deliver sialyltransferase‐inhibitor‐loaded core into cytoplasm, and anchor NK‐activating‐glycan‐modified shell onto tumor surface. This spatially‐differential distribution of core and shell in one cell ensures the effective inhibition of intracellular sialyltransferase to downregulate immunosuppressing sialic acid, and direct presentation of NK‐activating Lewis X trisaccharide (LeX) on tumor surface simultaneously. Consequentially, the sialic acid‐caused immunosuppression of tumor surface is reprogrammed to be LeX‐induced NK activation, resulting in sensitive susceptibility to NK‐cell‐mediated recognition and lysis for improved tumor elimination. This MFL provides a novel platform for multiplex cell engineering and personalized regulation of intercellular interactions for enhanced cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

N-Acetylneuraminic AcidNeoplasmsHumansCell MembranePolysaccharidesSialyltransferasesCell- and Tissue-Based TherapyTumor Microenvironment

Stichwörter der Autor:innen

cancer therapyinjectable hydrogelmembrane-fusogenic nanoparticlesnatural killer cellstumor surface glycan

Substanzen

N-Acetylneuraminic AcidPolysaccharidesSialyltransferases

Autor:innen und Institutionen

  • Laboratory of Biomaterials and Translational Medicine, Center for Nanomedicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China.
  • Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China.
  • Guangdong Provincial Key Laboratory of Liver Disease Research, Guangzhou, 510630, China.

ORCID-Profile: Xuesi Chen

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Science and Technology Program of Guangzhou
  • China Postdoctoral Science Foundation
  • China Primary Health Care Foundation
  • Guangdong Provincial Pearl River Talents Program

Zitieren

APA

Zheng, C., Zhong, Q., Song, W., Yi, K., Kong, H., Wang, H., Tao, Y., Li, M., & Chen, X. (2023). Membrane‐Fusion‐Mediated Multiplex Engineering of Tumor Cell Surface Glycans for Enhanced NK Cell Therapy. Advanced Materials. https://doi.org/10.1002/adma.202206989

Vancouver

Zheng C, Zhong Q, Song W, Yi K, Kong H, Wang H, et al. Membrane‐Fusion‐Mediated Multiplex Engineering of Tumor Cell Surface Glycans for Enhanced NK Cell Therapy. Advanced Materials. 2023. doi:10.1002/adma.202206989

BibTeX
@article{Zheng2023,
  author = {Zheng, Chunxiong and Zhong, Qingguo and Song, Wantong and Yi, Ke and Kong, Huimin and Wang, Haixia and Tao, Yu and Li, Mingqiang and Chen, Xuesi},
  title = {Membrane‐Fusion‐Mediated Multiplex Engineering of Tumor Cell Surface Glycans for Enhanced NK Cell Therapy},
  journal = {Advanced Materials},
  year = {2023},
  doi = {10.1002/adma.202206989}
}
Kostenlos starten →